Mary Banoub

506 total citations
17 papers, 147 citations indexed

About

Mary Banoub is a scholar working on Infectious Diseases, Surgery and Applied Microbiology and Biotechnology. According to data from OpenAlex, Mary Banoub has authored 17 papers receiving a total of 147 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 6 papers in Surgery and 5 papers in Applied Microbiology and Biotechnology. Recurrent topics in Mary Banoub's work include Antibiotic Use and Resistance (5 papers), Surgical site infection prevention (5 papers) and HIV Research and Treatment (4 papers). Mary Banoub is often cited by papers focused on Antibiotic Use and Resistance (5 papers), Surgical site infection prevention (5 papers) and HIV Research and Treatment (4 papers). Mary Banoub collaborates with scholars based in United States. Mary Banoub's co-authors include Emily L. Heil, Kimberly C. Claeys, Howard E. Gendelman, Jacqueline Bork, Katherine E Goodman, JoEllyn McMillan, Zhiyi Lin, Nagsen Gautam, Yazen Alnouti and Prasanta K. Dash and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Journal of Pharmacology and Experimental Therapeutics and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Mary Banoub

16 papers receiving 147 citations

Peers

Mary Banoub
Amelia N. Deitchman United States
Beatriz Larrú United States
Derek Cocker United Kingdom
Rebecca Sutherland United Kingdom
P. Viale Italy
Felix D. Rozenberg United States
Mary Banoub
Citations per year, relative to Mary Banoub Mary Banoub (= 1×) peers Rafaël Mahieu

Countries citing papers authored by Mary Banoub

Since Specialization
Citations

This map shows the geographic impact of Mary Banoub's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Banoub with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Banoub more than expected).

Fields of papers citing papers by Mary Banoub

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary Banoub. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Banoub. The network helps show where Mary Banoub may publish in the future.

Co-authorship network of co-authors of Mary Banoub

This figure shows the co-authorship network connecting the top 25 collaborators of Mary Banoub. A scholar is included among the top collaborators of Mary Banoub based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Banoub. Mary Banoub is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Heil, Emily L., Kimberly C. Claeys, Ellen G Kline, et al.. (2023). Early initiation of three-drug combinations for the treatment of carbapenem-resistant A. baumannii among COVID-19 patients. Journal of Antimicrobial Chemotherapy. 78(4). 1034–1040. 16 indexed citations
2.
Claeys, Kimberly C., et al.. (2023). Evaluating the Follow-up of Post-discharge Positive Sterile Site Cultures and the Impact on Infection-Related Complications. Infectious Diseases and Therapy. 12(3). 989–996.
3.
Goodman, Katherine E, Emily L. Heil, Kimberly C. Claeys, Mary Banoub, & Jacqueline Bork. (2022). Real-world Antimicrobial Stewardship Experience in a Large Academic Medical Center: Using Statistical and Machine Learning Approaches to Identify Intervention “Hotspots” in an Antibiotic Audit and Feedback Program. Open Forum Infectious Diseases. 9(7). ofac289–ofac289. 16 indexed citations
4.
Gandhapudi, Siva K., Karuna Sundarapandiyan, Afsheen Fatima, et al.. (2022). Abstract B24: Development of targeted T-cell cancer immunotherapies based on a novel enantiomeric cationic lipid that promotes antigen cross-presentation and upregulation of type I interferons. Cancer Immunology Research. 10(12_Supplement). B24–B24. 1 indexed citations
5.
Joshi, Manjari, et al.. (2021). Evaluation of Intra-Operative Topical Vancomycin and the Incidence of Acute Kidney Injury. Surgical Infections. 22(8). 810–817. 3 indexed citations
6.
Doub, James B., Jacqueline Bork, Emily L. Heil, et al.. (2021). Effectiveness and Safety of Biodegradable Calcium Sulfate Antibiotic Beads as Adjuvant Therapy in Vascular Graft Infections. Open Forum Infectious Diseases. 8(2). ofaa650–ofaa650. 7 indexed citations
7.
Vega, Ana, Emily L. Heil, Mary Banoub, et al.. (2020). Evaluation of Addition of Intravenous Metronidazole to Oral Vancomycin Therapy in Critically Ill Patients with Non‐Fulminant Severe Clostridioides difficile Infection. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 40(5). 398–407. 5 indexed citations
8.
Dash, Prasanta K., Bhavesh D. Kevadiya, Hang Su, Mary Banoub, & Howard E. Gendelman. (2020). Pathways towards human immunodeficiency virus elimination. EBioMedicine. 53. 102667–102667. 12 indexed citations
9.
Banoub, Mary, et al.. (2020). The Battle Is on: New Beta-Lactams for the Treatment of Multidrug-Resistant Gram-Negative Organisms. Current Infectious Disease Reports. 22(1). 1–1. 29 indexed citations
10.
Mazzeffi, Michael, et al.. (2020). Characterization of Postoperative Infection Risk in Cardiac Surgery Patients With Delayed Sternal Closure. Journal of Cardiothoracic and Vascular Anesthesia. 34(5). 1238–1243. 7 indexed citations
11.
Bork, Jacqueline, Kimberly C. Claeys, Emily L. Heil, et al.. (2020). A Propensity Score Matched Study of the Positive Impact of Infectious Diseases Consultation on Antimicrobial Appropriateness in Hospitalized Patients with Antimicrobial Stewardship Oversight. Antimicrobial Agents and Chemotherapy. 64(8). 7 indexed citations
12.
Vega, Ana, J. Kristie Johnson, Emily L. Heil, et al.. (2019). 2433. Oral Vancomycin Plus Intravenous Metronidazole for Severe Clostridioides difficile Infection in Critically Ill Patients. Open Forum Infectious Diseases. 6(Supplement_2). S841–S841. 1 indexed citations
13.
Banoub, Mary, Aditya N. Bade, Zhiyi Lin, et al.. (2019). Synthesis and Characterization of Long-Acting Darunavir Prodrugs. Molecular Pharmaceutics. 17(1). 155–166. 12 indexed citations
14.
Banoub, Mary, et al.. (2019). 1244. Evaluation of Intraoperative Topical Vancomycin and the Incidence of Acute Kidney Injury. Open Forum Infectious Diseases. 6(Supplement_2). S448–S448. 2 indexed citations
15.
Banoub, Mary, et al.. (2018). Higher versus Lower Dose of Cefotetan or Cefoxitin for Surgical Prophylaxis in Patients Weighing One Hundred Twenty Kilograms or More. Surgical Infections. 19(5). 504–509. 5 indexed citations
16.
Gautam, Nagsen, Zhiyi Lin, Mary Banoub, et al.. (2018). Simultaneous quantification of intracellular lamivudine and abacavir triphosphate metabolites by LC–MS/MS. Journal of Pharmaceutical and Biomedical Analysis. 153. 248–259. 14 indexed citations
17.
McMillan, JoEllyn, Zhiyi Lin, Mary Banoub, et al.. (2018). Antiretroviral Drug Metabolism in Humanized PXR-CAR-CYP3A-NOG Mice. Journal of Pharmacology and Experimental Therapeutics. 365(2). 272–280. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026